BioTime's CEO, Dr. Michael West to Moderate Session on Mapping...
The session will include world leaders in stem cell biology discussing how major advances in stem cell science and human health could be achieved by databasing the cellular components of the human body.
BioTime CEO Dr. Michael West to Present at 11th Annual Commercial...
BioTime, Inc. , a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, PhD will present at the 11th Annual Commercial Translation of Regenerative Medicine conference in London on Monday, November 25, 2013.
BioTime Announces Third Quarter 2013 Financial Results and Recent Corporate Accomplishments
BioTime, Inc. , a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the third quarter ended September 30, 2013 and highlighted recent corporate accomplishments.
BioTime, Inc. to Provide Company Updates During Investor Day, October 28, 2013
Chief Commercial Officer will provide an update on the development of Renevia . In his presentation, Dr. Tew will announce that enrollment in a safety trial evaluating Renevia , a proprietary injectable matrix designed to facilitate the stable engraftment of transplanted cells, is complete and the initial ten subjects who each received one ... (more)